No induction of apoptosis by IFN-β in human antigen-specific T cells

Neurology

Volumn 54, Issue 2, 2000, Pages 485-487

  Zipp, F ^a   Beyer, M ^b   Gelderblom, H ^b   Wernet, D ^b   Zschenderlein, R ^b   Weller, M ^b  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b NONE

Author keywords

Apoptosis; Caspase; CD95; Interferon ; MS

Indexed keywords

BETA INTERFERON; BETA1A INTERFERON; CASPASE; DNA FRAGMENT; FAS ANTIGEN; INTERFERON BETA SERINE;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IMMUNOMODULATION; MULTIPLE SCLEROSIS; PRIORITY JOURNAL; T LYMPHOCYTE;

EID: 0034711662     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/wnl.54.2.485     Document Type: Article

References (10)

1. Zipp F, Krammer PH, Weller M. Immune (dys)regulation in multiple sclerosis: role of the CD95/CD95 ligand system. Immunol Today 1999;20:550-554.
2. The IFNB Multiple Sclerosis Study Group, The University of British Columbia MS/MRI Analysis Group. Interferon beta-1b in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 1995;45:1277-1285.
3. Jacobs LD, Cookfair DL, Rudick RA, et al. The Multiple Sclerosis Collaborative Research Group (MSCRG): intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. Ann Neurol 1996;39:285-294.
4. PRISMS study group. Randomised double-blind placebo-controlled study of interferon beta-1a in relapsing/remitting multiple sclerosis. Lancet 1998;352:1498-1504.
5. European Study Group on Interferon Beta-1b in Secondary Progressive MS. Interferon beta-1b delays progression of disability in secondary progressive multiple sclerosis. Lancet 1998;352:1491-1497.
6. Pette M, Pette DF, Muraro PA, Farnon E, Martin R, McFarland HF. Interferon-β interferes with the proliferation but not with the cytokine secretion of myelin basic protein-specific, T-helper type 1 lymphocytes. Neurology 1997;49:385-392.
7. Zipp F, Martin R, Lichtenfels R, et al. Human autoreactive and foreign antigen-specific T cells resist apoptosis induced by soluble recombinant CD95 ligand. J Immunol 1997;159:2108-2115.
8. Pilling D, Akbar AN, Girdlestone J, et al. Interferon-β mediates stromal cell rescue of T cells from apoptosis. Eur J Immunol 1999;29:1041-1050.
9. Nagatani T, Okazawa H, Kambara T, et al. Effect of natural interferon-beta on the growth of melanoma cell lines. Melanoma Res 1998;8:295-299.
10. Rep MHG, Schrijver HM, van Lopik T, et al. Interferon (IFN)-β treatment enhances CD95 and interleukin 10 expression but reduces interferon-γ producing T cells in MS patients. J Neuroimmunol 1999;96:92-100.